We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

206 hedge funds and large institutions have $5.22B invested in Legend Biotech in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more call options, than puts

Call options by funds: $58.4M | Put options by funds: $19.4M

60% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 58

26% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 27

3% more funds holding

Funds holding: 200 → 206 (+6)

0.22% more ownership

Funds ownership: 26.05% → 26.27% (+0.22%)

10% less capital invested

Capital invested by funds: $5.78B → $5.22B (-$559M)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
206
Holders Change
+6
Holders Change %
+3%
% of All Funds
3%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
34
Increased
93
Reduced
58
Closed
27
Calls
$58.4M
Puts
$19.4M
Net Calls
+$39M
Net Calls Change
+$40.4M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$70.6M
2
Morgan Stanley
Morgan Stanley
New York
+$62.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$61M
4
BlackRock
BlackRock
New York
+$40.9M
5
Millennium Management
Millennium Management
New York
+$35.3M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$197M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$69.3M
3
NIP
Nicholas Investment Partners
California
-$35.9M
4
PCH
Polar Capital Holdings
United Kingdom
-$31.8M
5
HA
HHLR Advisors
Cayman Islands
-$28.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
201
GAMMA Investing
California
$3.58K +$4.12K +65 New
GWSG
202
GPS Wealth Strategies Group
Colorado
$2.71K +$2.85K +45 New
MIM
203
Macroview Investment Management
Maryland
$2.17K -$6.27K -99 -73%
EWA
204
EverSource Wealth Advisors
Alabama
$1.5K +$1.58K +25 New
VWWMG
205
Vermillion & White Wealth Management Group
Pennsylvania
$1.5K +$1.58K +25 New
AssetMark Inc
206
AssetMark Inc
California
$1.08K – – –
SC
207
Samlyn Capital
New York
– -$27.4M -407,546 Closed
Two Sigma Investments
208
Two Sigma Investments
New York
– -$13.2M -197,219 Closed
SFM
209
Soros Fund Management
New York
– -$6.05M -90,000 Closed
ACM
210
Atika Capital Management
New York
– -$4.57M -68,000 Closed
LIP
211
Lighthouse Investment Partners
Florida
– -$1.61M -23,975 Closed
GTC
212
Ghost Tree Capital
New York
– -$1.51M -22,500 Closed
Victory Capital Management
213
Victory Capital Management
Texas
– -$1.21M -17,959 Closed
State of New Jersey Common Pension Fund D
214
State of New Jersey Common Pension Fund D
New Jersey
– -$1.15M -17,047 Closed
SSA
215
Schonfeld Strategic Advisors
New York
– -$974K -14,500 Closed
XT
216
XTX Topco
Cayman Islands
– -$729K -10,850 Closed
GCM
217
Graham Capital Management
Connecticut
– -$716K -10,654 Closed
LCM
218
Legato Capital Management
California
– -$552K -8,222 Closed
ADIM
219
Alpha DNA Investment Management
Maryland
– -$533K -7,933 Closed
CCIA
220
Campbell & Co Investment Adviser
Maryland
– -$484K -7,201 Closed
CCS
221
Concentric Capital Strategies
Connecticut
– -$483K -7,188 Closed
AWM
222
AE Wealth Management
Kansas
– -$475K -7,065 Closed
M1FG
223
Mach-1 Financial Group
Arkansas
– -$472K -7,022 Closed
AR
224
Advisory Research
Illinois
– -$345K -5,131 Closed
AIM
225
Aigen Investment Management
New York
– -$320K -4,765 Closed
6 7 8
9
10

LEGN Hedge Fund Activity: Q4 2023 in Review

206 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2023, worth a combined $5.22B — down 9.7% from $5.78B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new LEGN positions and 27 closed out — a net gain of 7 holders — while 93 added to existing stakes and 58 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $70.6M. The largest seller was Fidelity Investments, cutting an estimated $197M.

  • 206 institutional investors held Legend Biotech (LEGN) as of Q4 2023, up from 200 in Q3 2023.
  • Funds reported $5.22B of Legend Biotech stock for Q4 2023, down 9.7% quarter-over-quarter.
  • 34 funds opened new Legend Biotech positions in Q4 2023 and 27 closed out, a net change of +7 holders.
  • The largest Legend Biotech buyer in Q4 2023 was T. Rowe Price Associates, an estimated $70.6M added.
  • The largest Legend Biotech seller in Q4 2023 was Fidelity Investments, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2023.